Symbol="ALKS"
AssetType="Common Stock"
Name="Alkermes Plc"
Description="Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland."
CIK="1520262"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4998581000"
EBITDA="-85795000"
PERatio="None"
PEGRatio="-1057.29"
BookValue="6.06"
DividendPerShare="0"
DividendYield="0"
EPS="-1"
RevenuePerShareTTM="6.83"
ProfitMargin="-0.146"
OperatingMarginTTM="-0.146"
ReturnOnAssetsTTM="-0.0523"
ReturnOnEquityTTM="-0.158"
RevenueTTM="1120845000"
GrossProfitTTM="893687000"
DilutedEPSTTM="-1"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.032"
AnalystTargetPrice="36.22"
TrailingPE="-"
ForwardPE="588.24"
PriceToSalesRatioTTM="3.643"
PriceToBookRatio="4.037"
EVToRevenue="3.566"
EVToEBITDA="-72.85"
Beta="0.605"
num_52WeekHigh="33.71"
num_52WeekLow="21.75"
num_50DayMovingAverage="30.58"
num_200DayMovingAverage="26.91"
SharesOutstanding="166121000"
DividendDate="None"
ExDividendDate="None"
symbol="ALKS"
open="30.47"
high="30.48"
low="30.06"
price="30.09"
volume="1377910.00"
latest_trading_day="2023-07-05"
previous_close="30.49"
change="-0.40"
change_percent="-1.3119%"
aroon_positive_momentum_days="99"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="99"
Volume_recent_avg="1308793"
Change_recent_avg="0.01"
Delta_recent_avg="0.7"
Variance_recent_avg="0.35"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="99"
Aroon_momentum_negative="1"
image_negative_thumbnail_id_1="156"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_negative_thumbnail_id_2="1148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="949"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
